Your session is about to expire
← Back to Search
Nightmare Reduction Techniques for Narcolepsy
N/A
Waitlist Available
Led By Jennifer Mundt, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of study (11-13 weeks)
Awards & highlights
Study Summary
This trial will test two treatments to reduce nightmares in narcolepsy patients. Participants will log sleep symptoms & complete questionnaires & a sleep study.
Who is the study for?
Adults with narcolepsy who often have nightmares (at least 3 times a week) can join this study. They must be stable on sleep and psychiatric meds for 3 months, speak English, live in the US, and be able to visit Evanston, IL for appointments. Those already in psychotherapy or with previous nightmare treatments cannot participate.Check my eligibility
What is being tested?
The trial is testing if imagery rehearsal therapy (IRT) helps reduce nightmares in people with narcolepsy and if adding targeted dream control (TDC) improves results. Participants will track their sleep, attend treatment sessions, fill out questionnaires, and some will do a sleep study nap.See study design
What are the potential side effects?
Since the interventions are behavioral therapies like IRT and TDC rather than medications, they may not have typical side effects but could include temporary increases in nightmare frequency or distress due to focusing on dreams during treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ duration of study (11-13 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of study (11-13 weeks)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Daily diary
Trial Design
2Treatment groups
Experimental Treatment
Group I: Imagery rehearsal therapy and targeted dream control (IRT+TDC)Experimental Treatment2 Interventions
Participants randomized to this group will receive 7 sessions of IRT+TDC.
Group II: Imagery rehearsal therapy (IRT)Experimental Treatment1 Intervention
Participants randomized to this group will receive 7 sessions of IRT.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,225 Total Patients Enrolled
2 Trials studying Narcolepsy
95 Patients Enrolled for Narcolepsy
Jennifer Mundt, PhDPrincipal InvestigatorNorthwestern University
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Narcolepsy
60 Patients Enrolled for Narcolepsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been taking the same sleep and psychiatric medications for at least 3 months.You are currently receiving counseling or therapy for mental health.You have received treatment for nightmares in the past.You are currently receiving regular medical treatment for narcolepsy.You have been diagnosed with narcolepsy.You have nightmares at least three times a week.You have a medical, mental, or memory condition that makes it difficult for you to participate in the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Imagery rehearsal therapy (IRT)
- Group 2: Imagery rehearsal therapy and targeted dream control (IRT+TDC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining slots for participants in this experiment?
"The details hosted on clinicaltrials.gov indicate that this particular trial is not currently recruiting participants; it was first posted in March 1st 2023 and last updated January 24th, 2023. Nevertheless, there are 12 other medical studies seeking enrollees of the moment."
Answered by AI
Who else is applying?
What site did they apply to?
Northwestern University
What portion of applicants met pre-screening criteria?
Met criteria
Why did patients apply to this trial?
Narcolepsy impacts my life a lot and I'd like there to be better treatments.
PatientReceived 2+ prior treatments
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger